3 Enzyme Maker, Glycol Producer and Edible Oil Stocks With a Strong Future Roadmap: Advanced Enzyme Technologies, India Glycols and AWL Agri Business

Enzyme maker, glycol producer and edible oil stocks give investors exposure to enzymes, chemicals and food staples used across industry and kitchens. Volumes, input costs and margins decide how much of that demand turns into profit.

This list covers three enzyme maker, glycol producer and edible oil stocks: Advanced Enzyme Technologies for enzymes and probiotics for food, nutrition, pharma and animal feed, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and AWL Agri Business for edible oils, packaged foods and staples sold under the Fortune brand. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Enzyme Maker, Glycol Producer and Edible Oil Stocks?

Enzyme maker, glycol producer and edible oil stocks are shares of companies that make chemicals and inputs for agriculture and industry. Results depend on input costs, volumes and pricing, so margins and cash flow separate the stronger names.

Enzyme Maker, Glycol Producer and Edible Oil Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three enzyme maker, glycol producer and edible oil stocks as of the 14 Oct 2026 close.

Among chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Enzyme Maker, Glycol Producer and Edible Oil Stocks Have a Strong Roadmap in India?

Enzyme maker, glycol producer and edible oil stocks have a strong roadmap in India because nutrition demand, ethanol blending and packaged food adoption keep adding volumes for these firms. Three drivers stand out.

• Nutrition demand: Food and feed makers use enzymes and probiotics.
• Renewable chemicals: Ethanol and bio-based chemicals gain policy support.
• Packaged staples: Branded oils and foods win share from loose products.

Advanced Enzyme Technologies: Enzymes and Probiotics Build the Next Leg

Advanced Enzyme's roadmap rests on enzymes and probiotics for food, nutrition, pharma and animal feed, with a wide industrial customer base supporting revenue.

Revenue grew from Rs 535.80 crore in FY22 to Rs 780.59 crore in FY26, a 45.7% rise, and FY26 revenue was 16.5% higher than FY25. FY26 net profit rose 29.6% to Rs 173.61 crore. Over four years, net profit rose from Rs 123.80 crore in FY22 to Rs 173.61 crore. In Q1 FY27, revenue grew 4.1% to Rs 202.81 crore. Operating margin was 37.06% in FY26.

Debt to equity is 0.02 and return on equity is 10.34%. FY26 operating cash flow was Rs 156.78 crore against capital expenditure of Rs 52.38 crore. Advanced Enzyme paid a dividend of Rs 5.35 per share for FY26, a yield of 2.02%. At a P/E of 17.28 against an industry P/E of 37.59, the stock trades below its industry multiple.

What to watch: The P/E of 17.28 against an industry P/E of 37.59 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

India Glycols: Green Chemicals and Ethanol Build the Next Leg

India Glycols' roadmap rests on glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock, with ethanol blending and chemical demand supporting volumes.

Revenue grew from Rs 2,889.84 crore in FY22 to Rs 4,216.34 crore in FY26, a 45.9% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 26.8% to Rs 292.76 crore. In Q1 FY27, revenue grew 19.3% to Rs 2,988.82 crore, and net profit rose 32.2% to Rs 96.83 crore. Operating margin was 7.12% in FY26.

Debt to equity is 0.58 and return on equity is 9.98%. FY26 operating cash flow was Rs 769.16 crore against capital expenditure of Rs 823.48 crore. India Glycols paid a dividend of Rs 7.5 per share for FY26, a yield of 2.10%. At a P/E of 7.58 against an industry P/E of 54.53, the stock trades below its industry multiple.

What to watch: The P/E of 7.58 against an industry P/E of 54.53 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

AWL Agri Business: Edible Oils and Staples Build the Next Leg

AWL Agri's roadmap rests on edible oils, packaged foods and staples sold under the Fortune brand, with a wide distribution network supporting volumes.

Revenue grew from Rs 54,327.16 crore in FY22 to Rs 75,148.47 crore in FY26, a 38.3% rise, and FY26 revenue was 17.6% higher than FY25. FY26 net profit was Rs 990.44 crore. In Q1 FY27, revenue grew 16.5% to Rs 20,116.91 crore, and net profit rose 47.7% to Rs 351.39 crore. Operating margin was 3.38% in FY26 and 3.90% in Q1 FY27 against 3.39% a year earlier.

Debt to equity is 0.11 and return on equity is 9.98%. FY26 operating cash flow was Rs 3,928.34 crore against capital expenditure of Rs 833.37 crore. AWL Agri paid a dividend of Rs 1 per share for FY26, a yield of 0.55%. At a P/E of 20.49 against an industry P/E of 34.85, the stock trades below its industry multiple.

What to watch: Net profit margin is only 1.3%, so small cost changes move earnings.

Best Enzyme Maker, Glycol Producer and Edible Oil Stocks in India: Advanced Enzyme vs India Glycols vs AWL Agri on Key Financials

Among the best enzyme maker, glycol producer and edible oil stocks in India, Advanced Enzyme leads on FY26 operating margin and return on equity; India Glycols leads on Q1 FY27 revenue growth and the lowest P/E; AWL Agri leads on FY26 revenue growth. The table puts the numbers side by side.

Chemical and agri earnings follow input costs, volumes and pricing, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Enzyme Maker, Glycol Producer and Edible Oil Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen enzyme maker, glycol producer and edible oil stocks and shortlist enzyme maker, glycol producer and edible oil stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check operating margin, debt and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these enzyme maker, glycol producer and edible oil stocks

Risks to Consider Before Investing in Enzyme Maker, Glycol Producer and Edible Oil Stocks

• Input costs: Changes in raw material prices can affect margins.
• Seasonal demand: Weather and crop cycles can shift sales between quarters.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Advanced Enzyme, India Glycols and AWL Agri live.

Final Take: Which Stock Has the Strongest Roadmap?

These three chemicals and consumer stocks cover enzymes, glycols and edible oils. Advanced Enzyme leads on FY26 operating margin and return on equity; India Glycols leads on Q1 FY27 revenue growth and the lowest P/E; AWL Agri leads on FY26 revenue growth.

Across enzyme maker, glycol producer and edible oil stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the enzyme maker, glycol producer and edible oil stocks to buy discussed here.

FAQs on Enzyme Maker, Glycol Producer and Edible Oil Stocks

Which are the best enzyme maker, glycol producer and edible oil stocks in India with a strong roadmap?

Ans. Advanced Enzyme Technologies, India Glycols and AWL Agri Business stand out for their roadmaps in enzymes, glycols and edible oils. FY26 revenue growth was 16.5% at Advanced Enzyme, 11.5% at India Glycols and 17.6% at AWL Agri, and return on equity ranges from 9.98% to 10.34%.

Is Advanced Enzyme Technologies a good stock to buy now?

Ans. Advanced Enzyme Technologies has a debt to equity ratio of 0.02, a return on equity of 10.34% and a P/E of 17.28 against an industry P/E of 37.59. Valuation, input costs and seasonal demand move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Advanced Enzyme, India Glycols and AWL Agri?

Ans. The P/E ratio is 17.28 for Advanced Enzyme (industry 37.59), 7.58 for India Glycols (industry 54.53) and 20.49 for AWL Agri (industry 34.85). All of them trade below the industry multiple.

Which of these enzyme maker, glycol producer and edible oil stocks has the highest return on equity?

Ans. Advanced Enzyme Technologies has the highest return on equity at 10.34%, followed by India Glycols at 9.98% and AWL Agri Business at 9.98%.

What are the risks of investing in enzyme maker, glycol producer and edible oil stocks?

Ans. The main risks are input costs, seasonal demand and quarterly trends. Changes in raw material prices can affect margins.

How did Advanced Enzyme, India Glycols and AWL Agri perform in Q1 FY27?

Ans. Advanced Enzyme Technologies reported revenue of Rs 202.81 crore, up 4.1% year on year. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. AWL Agri Business reported revenue of Rs 20,116.91 crore, up 16.5% year on year, and net profit rose 47.7% to Rs 351.39 crore.

Do enzyme maker, glycol producer and edible oil stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 2.02% for Advanced Enzyme, 2.10% for India Glycols and 0.55% for AWL Agri, based on dividends declared for FY26.

How can I invest in enzyme maker, glycol producer and edible oil stocks in India?

Ans. You can buy enzyme maker, glycol producer and edible oil stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.